Cancer spreads when cells break away from the original tumor, travel through the body, and establish new growths in distant organs. This process, called metastasis, is responsible for the majority of cancer-related deaths. Understanding how it works helps explain why early detection matters so much and why treatment changes once cancer has moved beyond its starting point.
The Step-by-Step Process of Metastasis
Spreading isn’t a single event. It’s a chain of steps, and a cancer cell has to successfully complete every one of them to form a new tumor somewhere else. First, cells in the original tumor undergo changes that let them detach from their neighbors. Normally, cells in tissues like the skin, breast, or colon are tightly bound together. Cancer cells can shift into a more mobile state, loosening those connections and gaining the ability to move independently. Multiple overlapping signals drive this transformation, including changes in how cells use energy and which genes they activate.
Once free, the mobile cancer cells push through the surrounding tissue and enter either the bloodstream or the lymphatic system, a network of vessels that drains fluid from tissues. Inside these highways, the cells face a hostile environment. The mechanical force of blood flow, attacks from immune cells, and the sheer stress of being unattached all kill the vast majority of circulating cancer cells. Only a tiny fraction survive long enough to reach a distant organ.
The survivors then have to exit the blood vessel, latch onto the new tissue, and begin dividing. This final step is far from guaranteed. Many cells that arrive at a distant site remain dormant for months or even years before growing, and some never grow at all. That’s why metastasis, despite being common, is actually a remarkably inefficient process at the cellular level.
Four Routes Cancer Uses to Travel
Not all cancers spread the same way. There are four main routes, and the type of cancer often determines which one it takes.
- Through the bloodstream. This is the most common path to distant organs. Cancer cells enter small blood vessels near the tumor, travel through the circulatory system, and lodge in capillary beds of organs like the lungs, liver, bones, or brain.
- Through the lymphatic system. Many cancers, especially breast cancer and melanoma, first spread to nearby lymph nodes before reaching distant sites. That’s why surgeons often check lymph nodes during cancer surgery to see whether spread has begun.
- Through body cavities. Some cancers can shed cells directly into open spaces inside the body. Ovarian cancer is the classic example. Malignant cells detach and float in the fluid that fills the abdominal cavity, forming small clumps that drift to the surfaces of nearby organs like the intestines or diaphragm. These clumps can survive in a free-floating state, then switch to an anchored, rapidly dividing state once they land on a new surface.
- By direct invasion. A tumor can simply grow large enough to push into adjacent organs or structures without needing to enter the bloodstream at all. A pancreatic tumor, for instance, may grow directly into the surrounding blood vessels or intestine.
Why Certain Cancers Favor Certain Organs
Cancer doesn’t spread randomly. Breast cancer tends to go to bone, liver, lungs, and brain. Colon cancer favors the liver. Lung cancer often reaches the brain and adrenal glands. This pattern puzzled scientists for over a century, until an idea first proposed in 1889 offered a lasting explanation.
Known as the “seed and soil” principle, the concept is straightforward: cancer cells (the seeds) can travel anywhere the blood carries them, but they can only grow if they land in an organ (the soil) that provides the right conditions. The distant organ isn’t just a passive destination. It actively influences whether arriving cancer cells survive, stay dormant, or thrive. The chemical signals, immune environment, and structural features of the tissue all play a role. This contradicted an earlier theory that spread was purely a matter of plumbing, with cancer cells simply getting stuck in whatever blood vessel network they encountered first.
Both factors matter in practice. Blood flow patterns do influence where cells end up initially. The liver, for example, receives all the blood draining from the intestines, which partly explains why colon cancer so often metastasizes there. But blood flow alone doesn’t explain the full picture. The molecular compatibility between the cancer cell and the organ environment determines whether a new tumor actually forms.
Signs That Cancer Has Spread
Metastatic cancer often announces itself through symptoms tied to the organ it has reached. According to the National Cancer Institute, common signs include:
- Bone: persistent pain, especially in the back or hips, and fractures from minor injuries
- Brain: headaches that worsen over time, seizures, dizziness, or changes in vision
- Lungs: shortness of breath or a cough that doesn’t go away
- Liver: yellowing of the skin (jaundice), swelling in the abdomen, or unexplained weight loss
These symptoms don’t always mean cancer has spread. But if you’ve been treated for cancer before, new and persistent symptoms in these areas are worth reporting promptly. Imaging scans and biopsies are used to confirm whether a new site of cancer is a metastasis from the original tumor or something unrelated.
How Staging Reflects Spread
Doctors use a staging system to describe how far a cancer has progressed. The most widely used framework assigns a number from I to IV. Stage I means the tumor is confined to where it started, with no involvement of nearby lymph nodes. Stage IV means cancer has spread to distant organs or to lymph nodes far from the original site.
This distinction matters enormously for treatment. A Stage I tumor can often be removed with surgery alone. Once cancer reaches Stage IV, it has seeded cells in locations that surgery typically can’t fully address, so the treatment strategy shifts.
How Treatment Changes Once Cancer Spreads
When cancer is localized, treatment targets the tumor directly: surgery to remove it, radiation to destroy it, or both. Once it spreads, the goal shifts to treating the entire body, because cancer cells may be present in multiple locations, including sites too small to show up on scans.
Systemic treatments, those that travel through the bloodstream to reach cells throughout the body, become the primary approach. Traditional chemotherapy remains an important tool, working by killing rapidly dividing cells. But the landscape has shifted significantly. For roughly half of patients with certain advanced cancers like non-small cell lung cancer, the first-line treatment now skips chemotherapy entirely in favor of newer options.
These newer options include targeted therapies, which attack specific molecular features that drive a particular tumor’s growth, and immunotherapy, which helps the immune system recognize and destroy cancer cells it was previously ignoring. In some cases, combining these approaches with chemotherapy works better than any single treatment, partly because chemotherapy may help expose cancer cells to the immune system while simultaneously killing them.
The practical reality for patients is that metastatic cancer typically requires ongoing treatment rather than a one-time intervention. Treatment cycles may continue for months or years, with regular imaging to track whether the cancer is shrinking, stable, or growing. The specific plan depends on where the cancer started, where it spread, and the molecular profile of the tumor cells, which can be identified through biopsy and genetic testing.
Why Metastasis Is Hard to Stop
One of the most challenging aspects of metastasis is that cancer cells aren’t static. Within a single tumor, cells exist in multiple states simultaneously, some more mobile, some more anchored, some more resistant to treatment. This diversity means that even when a treatment kills most of the cancer, a small population of cells with different characteristics may survive and eventually regrow.
Cancer cells can also lie dormant in distant organs for years after the original tumor was removed, reactivating long after a patient thought they were cancer-free. This is why some cancers recur five or ten years after successful initial treatment. The dormant cells were already in place, waiting for conditions that allowed them to start dividing again.
This complexity is why cancer treatment increasingly relies on molecular profiling rather than a one-size-fits-all approach. Two patients with the same type of cancer that has spread to the same organ may receive very different treatments based on the specific genetic changes driving their tumors. The more precisely treatment can be matched to the biology of the cancer, the better the chances of controlling its spread.